Bioanalysis Zone

Merck granted US Antitrust Clearance for Acquisition of Sigma-Aldrich


Merck KGaA (Darmstadt, Germany) has announced that it has now obtained antitrust clearance from the United States Federal Trade Commission for its planned acquisition of life science company Sigma-Aldrich (MO, USA).

In September 2014 the two companies announced that they had entered into a definitive agreement under which Merck KGaA would acquire Sigma-Aldrich for US$ 17.0 billion. The expiration of the Hart-Scott-Rodino Antitrust Improvements Act in December 2014 brings the merger one step closer to completion. The transaction now remains subject to a number of other conditions, including regulatory approval in other jurisdictions. According to Sigma-Aldrich, shareholders of the company approved the acquisition at a special meeting held in St. Louis (MO,USA) on 22 December, 2014.

Commenting on the merger agreement, Karl-Ludwig Kley, Chairman of Merck’s Executive Board said: “One of the world’s key industries two companies that fit perfectly together have found each other to present a much broader product offering to our global customers in research, pharma and biopharma manufacturing and diagnostic and testing labs. Kley added that, “the combination of Merck and Sigma-Aldrich will secure stable growth and profitability in an industry that is driven by trends such as the globalization of research and manufacturing.”

Source: Merck obtains US Antitrust clearance for acquisition of Sigma-Aldrich


Leave A Comment

Please wait...

Bioanalysis Zone New Investigator Award

Why not start this year by doing something good by nominating an early career scientist for the Bioanalysis Zone New Investigator Award. Complete the details below to register your interest!